Overexpression of miR-425-5p is associated with poor prognosis and tumor progression in non-small cell lung cancer

2020 ◽  
Vol 27 (2) ◽  
pp. 147-156
Author(s):  
Yongxing Fu ◽  
Yuanyuan Li ◽  
Xiaoyan Wang ◽  
Feng Li ◽  
Yugang Lu
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Tumor Progression ◽  
Cell Lung Cancer ◽  
Poor Prognosis ◽  
Small Cell ◽  
Small Cell Lung

scholarly journals Downregulation of m 6 A reader YTHDC2 promotes tumor progression and predicts poor prognosis in non‐small cell lung cancer

2020 ◽  
Vol 11 (11) ◽  
pp. 3269-3279 ◽  
Author(s):  
Shulei Sun ◽  
Qiang Han ◽  
Maoli Liang ◽  
Qian Zhang ◽  
Jing Zhang ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Tumor Progression ◽  
Cell Lung Cancer ◽  
Poor Prognosis ◽  
Small Cell ◽  
Small Cell Lung

scholarly journals MEOX1 Promotes Tumor Progression and Predicts Poor Prognosis in Human Non-Small-Cell Lung Cancer

2019 ◽  
Vol 16 (1) ◽  
pp. 68-74 ◽  
Author(s):  
Lichao Sun ◽  
Hebao Yuan ◽  
Joseph Burnett ◽  
Mari Gasparyan ◽  
Yuan Zhang ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Tumor Progression ◽  
Cell Lung Cancer ◽  
Poor Prognosis ◽  
Small Cell ◽  
Small Cell Lung

scholarly journals Overexpression of PP2A inhibitor SET oncoprotein is associated with tumor progression and poor prognosis in human non-small cell lung cancer

Oncotarget ◽  
2015 ◽  
Vol 6 (17) ◽  
pp. 14913-14925 ◽  
Author(s):  
Hao Liu ◽  
Yixue Gu ◽  
Hongsheng Wang ◽  
Jiang Yin ◽  
Guopei Zheng ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Tumor Progression ◽  
Cell Lung Cancer ◽  
Poor Prognosis ◽  
Small Cell ◽  
Small Cell Lung ◽  
Pp2a Inhibitor

scholarly journals High serum haptoglobin level is associated with tumor progression and predicts poor prognosis in non-small cell lung cancer

Oncotarget ◽  
2016 ◽  
Vol 7 (27) ◽  
pp. 41758-41766 ◽  
Author(s):  
Jianjun Lu ◽  
Yanhong Wang ◽  
Miansheng Yan ◽  
Pinning Feng ◽  
Linjing Yuan ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Tumor Progression ◽  
Cell Lung Cancer ◽  
Poor Prognosis ◽  
High Serum ◽  
Small Cell ◽  
Small Cell Lung ◽  
Serum Haptoglobin ◽  
Haptoglobin Level

LIFE SPAN PREDICTION AT METASTATIC NON-SMALL CELL LUNG CANCER

2018 ◽  
Vol 64 (4) ◽  
pp. 522-527
Author(s):  
Aleksey Shutko ◽  
Viktor Mus
Keyword(s):  
Lung Cancer ◽  
Stem Cells ◽  
Small Cell Lung Cancer ◽  
Life Span ◽  
Cell Lung Cancer ◽  
Poor Prognosis ◽  
Small Cell ◽  
Hemopoietic Stem Cells ◽  
Small Cell Lung ◽  
Individual Life

Individual parameters of circulating hemopoietic stem cells (HSC) lymphoid origin were measured by cytofluorometry before treatment of patients with metastatic non-small cell lung cancer and were retrospectively compared with individual life span's (LS). The possibility of poor prognosis of treatment's results (LS

Sign in / Sign up

Export Citation Format

Share Document